麻豆传媒

Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV/AIDS Vaccine Immunology (CHAVI), and a Professor of Medicine in the Department of Medicine at Duke University Medical Center. He is also an Affiliate Member of the Duke Global Health Institute. He has recently been appointed to the Duke University Fuqua School of Business Health Sector Advisory Council. Previously, he was an Associate Professor of Pathology, Laboratory Medicine and Pediatrics, Associate Professor of Preventive Medicine and Community Health and Assistant Dean for Research in Health Policy at the New Jersey Medical School, Newark, New Jersey. He has served on numerous committees for the NIH over the last two decades and currently is the principal investigator of an NIH portfolio in excess of 56 million dollars. Mr. Denny was a 2002-2003 Robert Wood Johnson Foundation Health Policy Fellow at the Institute of Medicine of the National Academies (IOM). As a fellow, he served on the US Senate Health, Education, Labor and Pensions Committee with legislation/policy responsibilities in global AIDS, bioterrorism, clinical trials/human subject protection and vaccine related-issues.

Paul A. Offit, MD, is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Offit is an internationally recognized expert in the fields of virology and immunology and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research, a member of the Institute of Medicine, and co-editor of the foremost vaccine text, Vaccines. He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, a Research Career Development Award from the National Institutes of Health, and the Sabin Vaccine Institute Gold Medal. Dr. Offit has published more than 150 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq®, recommended for universal use in infants by the CDC. For this achievement, Dr. Offit received the Luigi Mastroianni and William Osler Awards from the University of Pennsylvania School of Medicine, the Charles Mérieux Award from the National Foundation for Infectious Diseases, and was honored by Bill and Melinda Gates during the launch of their Foundation’s Living Proof Project for global health. In 2009, Dr. Offit received the President’s Certificate for Outstanding Service from the American Academy of Pediatrics. In 2011, he received the Humanitarian of the Year Award from the Biologics Industry Organization (BIO), the David E. Rogers Award from the American Association of Medical Colleges, the Odyssey Award from the Center for Medicine in the Public Interest, and was elected to the Institute of Medicine of the National Academy of Sciences. In 2012, Dr. Offit received the Distinguished Medical Achievement Award from the College of Physicians of Philadelphia and the Drexel Medicine Prize in Translational Medicine from the Drexel University College of Medicine. In 2013, he received the Maxwell Finland award for Outstanding Scientific Achievement from the National Foundation for Infectious Diseases, the Distinguished Alumnus award from the University of Maryland School of Medicine, and the Innovators in Health Award from the Group Health Foundation. In 2014, he was elected to the board of trustees at the College of Physicians in Philadelphia, and in 2015, he was elected to the American Association of Physicians and the American Academy of Arts and Sciences as well as being named as a Fellow for the Pediatric Infectious Diseases Society and the American Academy for the Advancement of Science. In 2016, Dr. Offit received the Franklin Founder Award by the City of Philadelphia, The Porter Prize from the University of Pittsburgh School of Public Health, and the Jonathan E. Rhoads Medal for Distinguished Service to Medicine from The American Philosophical Society. In 2017, he received the Defensor Scientiae Award and an Honorary Doctor of Science degree from The University of the Sciences in Philadelphia. In 2018, he was named to the Alpha Omega Alpha Honor Society at the University of Maryland School of Medicine.

Abdel-Mohsen鈥檚 research focuses on understanding the role of host glycosylation machinery in viral persistence and immunopathogenesis. 

Abdel-Mohsen joined The Wistar Institute as Assistant Professor in 2017 after completing his Ph.D. and postdoctoral training at the University of California, San Francisco (UCSF) and the Blood Systems Research Institute (BSRI), where he was subsequently appointed as a research scientist. Previously, he was a virologist for the World Health Organization Regional Reference Laboratory for poliovirus in his home country of Egypt. He received the UCSF-Gladstone CFAR Early-Career Award of Excellence in Basic Science in 2015.

Escolano investigates new vaccination approaches for highly mutating viruses. She received her bachelor’s of science degree from the University of Oviedo, Spain, and University of Turku, Finland, and a master’s degree from Centro de Biología Molecular Severo Ochoa, Madrid, and the Genome Research Institute (GRI), Cincinnati, Ohio. She obtained her Ph.D. in biochemistry and molecular biology from the Spanish National Center for Cardiovascular Research and Autonoma University, Madrid, and completed her postdoctoral training at The Rockefeller University, New York.

Sunil Thomas, PhD, is a research professor with the Lankenau Institute for Medical Research, part of Main Line Health. He created a groundbreaking resource for scientists seeking to develop new and better vaccines in the fight against COVID-19 called the COVID-19 Genetic Resource Guide鈥攖he world鈥檚 first compendium of the genetic code and protein structure of SARS-CoV-2. Dr. Thomas specializes in translational research, which applies scientific findings to medical practice. During his career in immunology, he has developed numerous therapeutic and diagnostic techniques and has been awarded several patents for his groundbreaking work. Dr. Thomas modeled the membrane protein (M) of SARS-CoV-2 and showed that it functions as a sugar transporter, and he modeled the transmembrane non-structural proteins of SARS-CoV-2. He is the editor of several books, including a popular two-volume set called Vaccine Design: Methods and Protocols (2016). A fully rewritten and supplemented second edition, consisting of three volumes, was published in 2022.

Christopher M. Walker, PhD, is director of the Center for Vaccines and Immunity at Nationwide Children's Hospital and holds the Wilby S. Cowan Endowed Chair in Pediatric Research.





 

Lori Handy, MD, MSCE, is a leading authority on pediatric infectious diseases, holding positions as attending physician in the Division of Infectious Diseases at The Children’s Hospital of Philadelphia (CHOP) and as an Assistant Professor of Clinical Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.
As Associate Director of CHOP’s Vaccine Education Center, Handy is at the forefront of vaccine advocacy and education. She consistently stays on the cutting edge on testing and treatment advancement and offers advice to help prevent outbreaks and support community health.
Additionally, her clinical experience gives her a unique perspective on the impact of diseases such as COVID-19, Flu, Measles, Strep and RSV on children and their families. When infections occur, she works closely with her pediatric patients and their families to minimize complications from medications, such as antibiotics, and ensure a speedy recovery for her patients.
She received her medical degree from The University of Pennsylvania and completed her residency in pediatrics and a fellowship in pediatric infectious diseases at CHOP. She also obtained a Master of Science in Clinical Epidemiology from Penn.
For more information about Handy and the Division of Infectious Diseases at CHOP, please visit .